Bioatla to host virtual kol event to review iaslc data on ba3011 in nsclc

San diego, nov. 28, 2023 (globe newswire) -- bioatla, inc. (nasdaq: bcab), a global clinical-stage biotechnology company focused on the development of conditionally active biologic (cab) antibody therapeutics for the treatment of solid tumors, today announced it will host a virtual kol event on monday, december 4, 2023 at 11:00 am et. to register, click here.
BCAB Ratings Summary
BCAB Quant Ranking